A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q

Cell
Young-Sun KangChae Gyu Park

Abstract

The intricate system of serum complement proteins provides resistance to infection. A pivotal step in the complement pathway is the assembly of a C3 convertase, which digests the C3 complement component to form microbial binding C3 fragments recognized by leukocytes. The spleen and C3 provide resistance against blood-borne S. pneumoniae infection. To better understand the mechanisms involved, we studied SIGN-R1, a lectin that captures microbial polysaccharides in spleen. Surprisingly, conditional SIGN-R1 knockout mice developed deficits in C3 catabolism when given S. pneumoniae or its capsular polysaccharide intravenously. There were marked reductions in proteolysis of serum C3, deposition of C3 on organisms within SIGN-R1(+) spleen macrophages, and formation of C3 ligands. We found that SIGN-R1 directly bound the complement C1 subcomponent, C1q, and assembled a C3 convertase, but without the traditional requirement for either antibody or factor B. The transmembrane lectin SIGN-R1 therefore contributes to innate resistance by an unusual C3 activation pathway.

References

Apr 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D M Musher
Jan 1, 1985·Immunology Letters·J H Humphrey
Jan 1, 1983·Annual Review of Immunology·D T Fearon, W W Wong
Sep 1, 1996·Journal of Neuroimmunology·S Sawant-ManeC L Koski
Apr 5, 2001·The New England Journal of Medicine·M J Walport
Jun 21, 2001·Immunological Reviews·H StoiberM P Dierich
Sep 20, 2001·The Journal of General Virology·N A Mabbott, M E Bruce
Oct 3, 2001·International Immunology·C G ParkR M Steinman
May 30, 2002·Nature Reviews. Immunology·Flavius Martin, John F Kearney
May 30, 2002·Nature Reviews. Immunology·Teizo Fujita
Jun 22, 2002·The Pediatric Infectious Disease Journal·Gordon E SchutzeSheldon L Kaplan
Jul 20, 2002·The Lancet Infectious Diseases·Javier Garau
Dec 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jeremy S BrownMarina Botto
Dec 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Young-Sun KangChae Gyu Park
Apr 21, 2004·International Immunology·Kazuhiko TakaharaKayo Inaba
Nov 17, 2004·Clinical and Experimental Immunology·A P M AtkinsonD C Kilpatrick
Dec 8, 2004·The Journal of Experimental Medicine·Astrid LanoueAndrew N J McKenzie
Mar 15, 2005·AIDS·Zoltán BánkiHeribert Stoiber
Aug 2, 2005·Nature Reviews. Immunology·Reina E Mebius, Georg Kraal
Aug 17, 2005·European Journal of Clinical Investigation·M KarsA van de Wiel

❮ Previous
Next ❯

Citations

Oct 30, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Gaëlle Le FriecClaudia Kemper
Aug 31, 2006·Cell and Tissue Research·Botond-Zoltán IgyártóImre Oláh
Dec 16, 2006·Nature Reviews. Immunology·Claudia Kemper, John P Atkinson
Sep 5, 2009·Nature Reviews. Immunology·Peter F Zipfel, Christine Skerka
Jan 26, 2013·Nature Reviews. Immunology·Andrea CeruttiIrene Puga
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christian RutemarkBirgitta Heyman
Dec 21, 2012·The Journal of Experimental Medicine·Xin-Jiang LuLei Xu
Dec 27, 2007·Viral Immunology·Kara L CummingsYoung S Hahn
Jul 22, 2010·Respirology : Official Journal of the Asian Pacific Society of Respirology·Gavin K Paterson, Carlos J Orihuela
Jul 8, 2011·Clinical Microbiology Reviews·Barry B Mook-KanamoriDiederik van de Beek
Jan 1, 2009·Journal of Innate Immunity·Kristin M Rogers, Mark Heise
Feb 14, 2012·Journal of Innate Immunity·Joke M M den Haan, Georg Kraal
Apr 11, 2012·Journal of Innate Immunity·Elizabeth E Gray, Jason G Cyster
Oct 25, 2011·PloS One·Catherine HyamsJeremy S Brown
Sep 12, 2007·PLoS Pathogens·Jose YusteJeremy S Brown
Nov 3, 2012·Clinical & Developmental Immunology·Sean R StowellJeanne E Hendrickson
Apr 13, 2013·Seminars in Immunopathology·Joke M M den Haan, Luisa Martinez-Pomares
Jan 12, 2011·Annual Review of Immunology·Santiago F GonzalezMichael C Carroll
Jun 15, 2011·Advanced Drug Delivery Reviews·Morten HarboeTom Eirik Mollnes
Feb 22, 2011·Immunology Letters·Leendert A Trouw, Mohamed R Daha
Jun 19, 2010·Journal of Immunological Methods·Cheolho CheongChae Gyu Park
Nov 3, 2009·Lancet·Tom van der Poll, Steven M Opal
Oct 28, 2008·Developmental and Comparative Immunology·Y W HuangX J Meng
Jun 8, 2007·Journal of Immunological Methods·Cheolho CheongChae Gyu Park
Jun 17, 2015·Biochemical and Biophysical Research Communications·Jin-Yeon ParkYoung-Sun Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.